サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1576953

ラテラルフローリーダー/アッセイ - 市場考察、競合情勢、市場予測（2030年）

Lateral Flow Readers/Assays - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日
発行
DelveInsight
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
ラテラルフローリーダー/アッセイ - 市場考察、競合情勢、市場予測（2030年）
出版日: 2024年10月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のラテラルフローリーダー/アッセイの市場規模は、2023年に86億4,000万米ドルであり、2030年までに121億5,000万米ドルに達すると予測され、2024年～2030年の予測期間にCAGRで5.41％の成長が見込まれます。市場は、HIV、B型肝炎、C型肝炎、インフルエンザなどの感染症患者の増加、主要企業による革新的な新製品の導入などにより大きな成長を示しており、これらが2024年～2030年の予測期間に市場全体の成長に寄与する大きな要因として作用しています。

ラテラルフローリーダー/アッセイの市場力学

世界保健機関（WHO）の2024年の発表によると、2022年に世界で約3,900万人がHIV感染症に罹患していました。この資料はまた、約3,750万人が成人（15歳以上）であり、約150万人が15歳未満の小児であると述べています。感染症診断は、HIV感染を特定し、早期発見、治療モニタリング、伝染予防を可能にする上で極めて重要です。ラテラルフローリーダー/アッセイは、HIV抗体や抗原を迅速かつ治療現場で検出できる、HIV診断に不可欠なツールです。感染の早期発見を可能にし、タイムリーな介入と治療のモニタリングを可能にします。

WHO（2024年）のデータによると、2022年に世界中で3億400万人がB型/C型肝炎に感染しています。ラテラルフローリーダー/アッセイは、血液または血清サンプル中の特定の抗原または抗体を検出することにより、迅速かつ効率的にB型/C型肝炎を診断するために使用されます。これらの検査は、治療現場で迅速な結果を提供し、特にリソースが限られた環境において、感染の早期発見とモニタリングを可能にします。

さらに、市場各社による革新的な新製品の導入が、同製品の市場シェアを押し上げています。例えば2023年2月、Thermo Fisherはインドで感染症検出用のリアルタイムPCRキットを発表しました。Applied BiosystemsのTaqPath PCRキットは、多剤耐性結核（MDR-TB）、結核菌群（MTB）、B型肝炎（HBV）、C型肝炎（HCV）、HIV、HLA-B27のような遺伝子の分析に対する診断の開発と検査において信頼性と確信を提供するように設計されています。

したがって、上記のすべての要因の相互作用が、2024年～2030年の予測期間にラテラルフローリーダー/アッセイ市場を牽引する見込みです。

しかし、正確な診断検査や機器の開発における課題、代替の処置の利用可能性などが、ラテラルフローリーダー/アッセイ市場の成長を抑制する可能性があります。

ラテラルフローリーダー/アッセイ市場のセグメント分析

ラテラルフローリーダー/アッセイ市場の製品セグメントでは、キット・試薬カテゴリが2023年に大きな収益シェアを占めると予測されています。ラテラルフローリーダー/アッセイのキット・試薬の急成長は、複数の特徴的な機能と利点を提供するその広く活用されたアプローチによるもので、人々に好まれる選択肢となっています。

これらのキットには通常、ラテラルフローテストストリップ、サンプル調製用試薬、時にはアッセイを実施するために必要な緩衝液や希釈液が含まれています。これらのキットと試薬の特徴は、その簡便性、利便性、汎用性にあります。治療現場用に設計されているため、複雑な検査インフラを必要とせず、診療所や病院、さらには家庭での診断などのさまざまな環境での迅速検査に理想的です。

ラテラルフローキットと試薬の主な特徴は、特定のバイオマーカー、抗原、または抗体を検出する能力であり、感染症（COVID-19、HIV、マラリアなど）の診断、慢性疾患（糖化ヘモグロビン検出による糖尿病など）のモニタリング、心イベントの評価（心臓発作症例におけるトロポニン値の検出など）に適しています。さらに、これらのキットは通常、特定のターゲット向けにあらかじめ設定されており、これは検査対象の状態に非常に特異的であることを意味します。しかし、感度は使用する試薬の設計や品質によって異なる可能性があります。

したがって、先に述べた要因により、キット・試薬カテゴリの需要が急増し、結果としてこのカテゴリはかなりの成長を示すと予測され、2024年～2030年の予測期間におけるラテラルフローリーダー/アッセイ市場全体の成長に寄与します。

当レポートでは、世界のラテラルフローリーダー/アッセイ市場について調査分析し、各地域の市場規模と予測、過去3年の製品/技術開発、市場の主要企業、将来の機会などの情報を提供しています。

目次

第1章 ラテラルフローリーダー/アッセイ市場レポートのイントロダクション

第2章 ラテラルフローリーダー/アッセイ市場のエグゼクティブサマリー

  • 市場の概要

第3章 競合情勢

第4章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第5章 ラテラルフローリーダー/アッセイ市場の主な要因の分析

  • ラテラルフローリーダー/アッセイ市場の促進要因
  • ラテラルフローリーダー/アッセイ市場の抑制要因と課題
  • ラテラルフローリーダー/アッセイ市場の機会

第6章 ラテラルフローリーダー/アッセイ市場のポーターのファイブフォース分析

第7章 ラテラルフローリーダー/アッセイ市場の評価

  • 製品別
    • リーダー
    • キット・試薬
  • 技法別
    • サンドイッチアッセイ
    • 競合アッセイ
    • マルチプレックス検出アッセイ
  • 用途別
    • 臨床試験
    • 医薬品開発・品質検査
    • その他
  • エンドユーザー別
    • 病院・診療所
    • 在宅ケア
  • 地域
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 ラテラルフローリーダー/アッセイ市場の企業と製品のプロファイル

  • Abbott
  • Quidel Corporation
  • Danaher Corporation
  • Siemens Healthineers
  • F. Hoffman-La Roche AG
  • LumiraDx
  • BD
  • Eurofins Technologies
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific
  • Hologic, Inc.
  • PerkinElmer Inc.
  • QIAGEN
  • Merck KGaA
  • OPERON
  • Abingdon Health
  • DIALUNOX
  • 3B BlackBio Biotech India Ltd.
  • ADS Biotec Inc.

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Lateral Flow Readers/Assay Market in Global (2021-2030)
  • Table 3: Lateral Flow Readers/Assay Market in Global by Product (2021-2030)
  • Table 4: Lateral Flow Readers/Assay Market in Global by Technique (2021-2030)
  • Table 5: Lateral Flow Readers/Assay Market in Global by Application (2021-2030)
  • Table 6: Lateral Flow Readers/Assay Market in Global by End-User (2021-2030)
  • Table 7: Lateral Flow Readers/Assay Market in Global by Geography (2021-2030)
  • Table 8: Lateral Flow Readers/Assay Market in North America (2021-2030)
  • Table 9: Lateral Flow Readers/Assay Market in the United States (2021-2030)
  • Table 10: Lateral Flow Readers/Assay Market in Canada (2021-2030)
  • Table 11: Lateral Flow Readers/Assay Market in Mexico (2021-2030)
  • Table 12: Lateral Flow Readers/Assay Market in Europe (2021-2030)
  • Table 13: Lateral Flow Readers/Assay Market in France (2021-2030)
  • Table 14: Lateral Flow Readers/Assay Market in Germany (2021-2030)
  • Table 15: Lateral Flow Readers/Assay Market in United Kingdom (2021-2030)
  • Table 16: Lateral Flow Readers/Assay Market in Italy (2021-2030)
  • Table 17: Lateral Flow Readers/Assay Market in Spain (2021-2030)
  • Table 18: Lateral Flow Readers/Assay Market in the Rest of Europe (2021-2030)
  • Table 19: Lateral Flow Readers/Assay Market in Asia-Pacific (2021-2030)
  • Table 20: Lateral Flow Readers/Assay Market in China (2021-2030)
  • Table 21: Lateral Flow Readers/Assay Market in Japan (2021-2030)
  • Table 22: Lateral Flow Readers/Assay Market in India (2021-2030)
  • Table 23: Lateral Flow Readers/Assay Market in Australia (2021-2030)
  • Table 24: Lateral Flow Readers/Assay Market in South Korea (2021-2030)
  • Table 25: Lateral Flow Readers/Assay Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Lateral Flow Readers/Assay Market in the Rest of the World (2021-2030)
  • Table 27: Lateral Flow Readers/Assay Market in the Middle East (2021-2030)
  • Table 28: Lateral Flow Readers/Assay Market in Africa (2021-2030)
  • Table 29: Lateral Flow Readers/Assay Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Lateral Flow Readers/Assay Market in Global (2021-2030)
  • Figure 3: Lateral Flow Readers/Assay Market in Global by Product (2021-2030)
  • Figure 4: Lateral Flow Readers/Assay Market in Global by Technique (2021-2030)
  • Figure 5: Lateral Flow Readers/Assay Market in Global by Application (2021-2030)
  • Figure 6: Lateral Flow Readers/Assay Market in Global by End-User (2021-2030)
  • Figure 7: Lateral Flow Readers/Assay Market in Global by Geography (2021-2030)
  • Figure 8: Lateral Flow Readers/Assay Market in North America (2021-2030)
  • Figure 9: Lateral Flow Readers/Assay Market in the United States (2021-2030)
  • Figure 10: Lateral Flow Readers/Assay Market in Canada (2021-2030)
  • Figure 11: Lateral Flow Readers/Assay Market in Mexico (2021-2030)
  • Figure 12: Lateral Flow Readers/Assay Market in Europe (2021-2030)
  • Figure 13: Lateral Flow Readers/Assay Market in France (2021-2030)
  • Figure 14: Lateral Flow Readers/Assay Market in Germany (2021-2030)
  • Figure 15: Lateral Flow Readers/Assay Market in United Kingdom (2021-2030)
  • Figure 16: Lateral Flow Readers/Assay Market in Italy (2021-2030)
  • Figure 17: Lateral Flow Readers/Assay Market in Spain (2021-2030)
  • Figure 18: Lateral Flow Readers/Assay Market in the Rest of Europe (2021-2030)
  • Figure 19: Lateral Flow Readers/Assay Market in Asia-Pacific (2021-2030)
  • Figure 20: Lateral Flow Readers/Assay Market in China (2021-2030)
  • Figure 21: Lateral Flow Readers/Assay Market in Japan (2021-2030)
  • Figure 22: Lateral Flow Readers/Assay Market in India (2021-2030)
  • Figure 23: Lateral Flow Readers/Assay Market in Australia (2021-2030)
  • Figure 24: Lateral Flow Readers/Assay Market in South Korea (2021-2030)
  • Figure 25: Lateral Flow Readers/Assay Market in Rest of Asia-Pacific (2021-2030)
  • Figure 26: Lateral Flow Readers/Assay Market in the Rest of the World (2021-2030)
  • Figure 27: Lateral Flow Readers/Assay Market in the Middle East (2021-2030)
  • Figure 28: Lateral Flow Readers/Assay Market in Africa (2021-2030)
  • Figure 29: Lateral Flow Readers/Assay Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Marker Opportunities
  • Figure 33: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0530

Lateral Flow Readers/Assay Market by Product (Readers [Bench-top Readers, Digital/Mobile Readers], and Kits & Reagents), Technique (Sandwich Assays, Competitive Assays, and Multiplex Detection Assays), Application (Clinical Testing [Pregnancy Testing, Infectious Diseases Testing, Cardiac Marker Testing, and Others], Drug Development & Quality Testing, and Others), End-User (Hospitals & Clinics, Home Care, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the growing instances of infectious diseases and rising product developmental activities worldwide

The lateral flow readers/assay market was valued at USD 8.64 billion in 2023, growing at a CAGR of 5.41% during the forecast period from 2024 to 2030 to reach USD 12.15 billion by 2030. The lateral flow readers/assay market is experiencing significant growth due to the increasing cases of infectious diseases including HIV, hepatitis B & C, and influenza, the introduction of new and innovative products by key players, and others that are acting as major factors contributing to the overall growth of the lateral flow readers/assay market during the forecast period from 2024 to 2030.

Lateral Flow Readers/Assay Market Dynamics:

As per the World Health Organization (WHO) 2024, nearly 39 million people were living with HIV infection in 2022, globally. The source also stated that nearly 37.5 million were adults (aged 15 and above) and approximately 1.5 million people were children, aged less than 15 years. Infectious disease diagnostics are crucial in identifying HIV infection, enabling early detection, treatment monitoring, and preventing transmission. Lateral flow readers/assays are essential tools in HIV diagnostics, offering rapid, point-of-care detection of HIV antibodies or antigens. They enable early identification of infection, allowing for timely intervention and treatment monitoring.

Data from the WHO 2024, stated that 304 million people were infected by hepatitis B and C across the world in the year 2022. The same source further stated that out of these 254 million were afflicted by hepatitis B and 50 million were affected by hepatitis C. Lateral flow readers/assays are used to quickly and efficiently diagnose hepatitis B and C by detecting specific antigens or antibodies in blood or serum samples. These tests provide rapid results at the point of care, enabling early detection and monitoring of infections, particularly in resource-limited settings.

Additionally, the introduction of new and innovative products by market players are pushing forward the market share for same. For example, in February 2023, Thermo Fisher introduced real-time PCR kits in India for the detection of infectious diseases. The Applied Biosystems TaqPath PCR kits are designed to provide confidence and reliability in diagnostic development and testing for conditions like Multi-Drug Resistant Tuberculosis (MDR-TB), M. Tuberculosis complex (MTB), Hepatitis B (HBV), Hepatitis C (HCV), HIV, and for genetic analysis such as HLA-B27.

Hence, the interplay of all the above-mentioned factors is expected to drive the lateral flow readers/assay market during the given forecast period from 2024 to 2030.

However, challenges in the development of accurate diagnostic tests and equipment, and the availability of alternative procedures, among others may restrict the market growth for the lateral flow readers/assay market.

Lateral Flow Readers/Assay Market Segment Analysis:

Lateral Flow Readers/Assay Market by Product (Readers [Bench-top Readers, Digital/Mobile Readers], and Kits & Reagents), Technique (Sandwich Assays, Competitive Assays, and Multiplex Detection Assays), Application (Clinical Testing [Pregnancy Testing, Infectious Diseases Testing, Cardiac Marker Testing, and Others], Drug Development & Quality Testing, and Others), End-User (Hospitals & Clinics, Home Care, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the lateral flow readers/assay market, the kits & reagents category is expected to have a significant revenue share in the year 2023. The rapid growth of the kits & reagents of lateral flow readers/assay is due to its widely utilized approach that offers several distinctive features and benefits, making it a preferred option for people.

These kits typically include the lateral flow test strips, reagents for sample preparation, and sometimes buffers or diluents necessary for running the assay. The distinctive features of these kits and reagents lie in their simplicity, convenience, and versatility. Designed for point-of-care use, they do not require complex laboratory infrastructure, which makes them ideal for rapid testing in various settings such as clinics, hospitals, and even home diagnostics.

A key feature of lateral flow kits and reagents is their ability to detect specific biomarkers, antigens, or antibodies, making them suitable for diagnosing infectious diseases (such as COVID-19, HIV, or malaria), monitoring chronic conditions (like diabetes through glycated hemoglobin detection), and assessing cardiac events (e.g., detecting troponin levels in heart attack cases). Moreover, these kits are typically pre-configured for a specific target, meaning they are highly specific to the condition being tested for. However, sensitivity can vary depending on the design and quality of the reagents used.

Therefore, owing to the factors mentioned earlier, the demand for the kits & reagents category upsurges, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the lateral flow readers/assay market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall lateral flow readers/assay market:

Among all the regions, North America is estimated to hold a significant revenue share in the lateral flow readers/assay market. This domination is due to the growing burden of infectious diseases including tuberculosis, outbreaks of influenza, emerging pathogens, growing product developmental activities, presence of key manufacturers, among others that are expected to fuel the lateral flow readers/assay market in the region during the forecast period from 2024 to 2030.

Public Health Agency of Canada (2024), stated that in 2022, there were 1,971 active tuberculosis cases in Canada. Lateral flow readers/assays are used in tuberculosis diagnostics to provide rapid, point-of-care detection of TB antigens or antibodies. These tests help identify active TB cases by detecting Mycobacterium tuberculosis-specific proteins, aiding in early diagnosis and timely treatment.

Advancements in technology, such as the development of rapid diagnostic tests and molecular assays, enhance the accuracy and speed of diagnoses, making testing more accessible. The increase in point-of-care testing is also contributing to the market, allowing immediate results in clinical settings.

Rising product developmental activities by regulatory bodies in the region are likely to push forward the revenue shares for the same. For example, in November 2023, Abbott announced that it received the U.S. Food and Drug Administration (FDA) approval for its human papillomavirus or HPV screening solution.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the lateral flow readers/assay market during the forecast period from 2024 to 2030.

Lateral Flow Readers/Assay Market key players:

Some of the key market players operating in the lateral flow readers/assay market include Abbott, Quidel Corporation, Danaher Corporation, Siemens Healthineers, F. Hoffman-La Roche AG, LumiraDx, BD, Eurofins Technologies, bioMerieux SA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Hologic, Inc., PerkinElmer Inc., QIAGEN, Merck KGaA, OPERON, Abingdon Health, DIALUNOX, 3B BlackBio Biotech India Ltd., ADS Biotec Inc., and others.

Recent Developmental Activities in the Lateral Flow Readers/Assay Market:

  • In January 2021, LumiraDx announced multinational approvals of its SARS-CoV-2 Antigen Test. With approvals in Japan and Brazil, the fast, accurate LumiraDx SARS-CoV-2 Antigen Test was made available to patients in more than 30 nations worldwide.
  • In January 2021, ADS Biotec announced the European launch and immediate availability of its COVID-19 Rapid Antigen Test. The company obtained a CE mark for the industry's first Rapid Antigen Test that works with both nasal swabs and blood serum, using proven fluorescence immunochromatographic lateral flow technology, providing an easy-to-use test for COVID-19 infection within 15 minutes.

Key takeaways from the Lateral Flow Readers/Assay market report study

  • Market size analysis for current lateral flow readers/assay market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the lateral flow readers/assay market
  • Various opportunities available for the other competitors in the lateral flow readers/assay market space
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current lateral flow readers/assay market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for lateral flow readers/assay market growth in the coming future?

Target audience who can be benefited from this Lateral Flow Readers/Assay market report study

  • Lateral flow readers/assay device providers
  • Research organizations and consulting companies
  • Lateral flow readers/assay related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in lateral flow readers/assay
  • Various end-users who want to know more about the lateral flow readers/assay market and the latest developments in the lateral flow readers/assay market

Frequently Asked Questions for the Lateral Flow Readers/Assay Market:

1. What are Lateral Flow Readers/Assay?

  • The lateral flow readers/assay are simple diagnostic devices that are used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds. The most commonly known type of lateral flow rapid test strip is the pregnancy test.

2. What is the market for Lateral Flow Readers/Assay?

  • The lateral flow readers/assay market was valued at USD 8.64 billion in 2023, growing at a CAGR of 5.41% during the forecast period from 2024 to 2030 to reach USD 12.15 billion by 2030.

3. What are the drivers for the Lateral Flow Readers/Assay market?

  • The lateral flow readers/assay market is experiencing significant growth due to the increasing cases of infectious diseases including HIV, hepatitis B & C, and influenza, the introduction of new and innovative products by key players, and others that are acting as major factors contributing to the overall growth of the lateral flow readers/assay market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Lateral Flow Readers/Assay market?

  • Some of the major market key players operating in the lateral flow readers/assay market include Abbott, Quidel Corporation, Danaher Corporation, Siemens Healthineers, F. Hoffman-La Roche AG, LumiraDx, BD, Eurofins Technologies, bioMerieux SA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Hologic, Inc., PerkinElmer Inc., QIAGEN, Merck KGaA, OPERON, Abingdon Health, DIALUNOX, 3B BlackBio Biotech India Ltd., ADS Biotec Inc., and others.

5. Which region has the highest share in the Lateral Flow Readers/Assay market?

Among all the regions, North America is estimated to hold a significant revenue share in the lateral flow readers/assay market. This domination is due to the growing burden of infectious diseases including tuberculosis, outbreaks of influenza, emerging pathogens, growing product developmental activities, presence of key manufacturers, among others that are expected to fuel the lateral flow readers/assay market in the region during the forecast period from 2024 to 2030.

Table of Contents

1. Lateral Flow Readers/Assay Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Lateral Flow Readers/Assay Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Lateral Flow Readers/Assay Market Key Factors Analysis

  • 5.1. Lateral Flow Readers/Assay Market Drivers
    • 5.1.1. Growing instances of infectious diseases
    • 5.1.2. Rising cardiovascular disorders
    • 5.1.3. Increasing pregnancy diagnostics
    • 5.1.4. Rising product developmental activities
  • 5.2. Lateral Flow Readers/Assay Market Restraints and Challenges
    • 5.2.1. Challenges in the development of accurate diagnostic tests and equipment
    • 5.2.2. Availability of alternative procedure
  • 5.3. Lateral Flow Readers/Assay Market Opportunities
    • 5.3.1. Integration of AI and ML for data interpretation
    • 5.3.2. Biomarker expansion for early infectious disease detection

6. Lateral Flow Readers/Assay Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Lateral Flow Readers/Assay Market Assessment

  • 7.1. By Product
    • 7.1.1. Readers
      • 7.1.1.1. Bench-top Readers
      • 7.1.1.2. Digital/Mobile Readers
    • 7.1.2. Kits & Reagents
  • 7.2. By Technique
    • 7.2.1. Sandwich Assays
    • 7.2.2. Competitive Assays
    • 7.2.3. Multiplex Detection Assays
  • 7.3. By Application
    • 7.3.1. Clinical Testing
      • 7.3.1.1. Pregnancy Testing
      • 7.3.1.2. Infectious Diseases Testing
      • 7.3.1.3. Cardiac Marker Testing
      • 7.3.1.4. Others
    • 7.3.2. Drug Development & Quality Testing
    • 7.3.3. Others
  • 7.4. By End-User
    • 7.4.1. Hospitals & Clinics
    • 7.4.2. Home Care
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.1.2. Canada Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.1.3. Mexico Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
    • 7.5.2. Europe
      • 7.5.2.1. France Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.2.2. Germany Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.2.3. United Kingdom Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.2.4. Italy Lateral Flow Readers/Assay market size in USD million (2021-2030)
      • 7.5.2.5. Spain Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.2.6. Rest of Europe Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.3.2. Japan Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.3.3. India Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.3.4. Australia Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.3.5. South Korea Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.3.6. Rest of Asia-Pacific Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.4.2. Africa Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.4.3. South America Lateral Flow Readers/Assay Market Size in USD million (2021-2030)

8. Lateral Flow Readers/Assay Market Company and Product Profiles

  • 8.1. Abbott
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Quidel Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Danaher Corporation
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Siemens Healthineers
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. F. Hoffman-La Roche AG
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. LumiraDx
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. BD
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Eurofins Technologies
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. bioMerieux SA
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Bio-Rad Laboratories, Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Thermo Fisher Scientific
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Hologic, Inc.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. PerkinElmer Inc.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. QIAGEN
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Merck KGaA
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. OPERON
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Abingdon Health
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. DIALUNOX
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. 3B BlackBio Biotech India Ltd.
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. ADS Biotec Inc.
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us